Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma.

Autor: Morecroft R; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, United States., Phillipps J; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, United States., Zhou A; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, United States., Butt O; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, United States., Khaddour K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States., Johanns T; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, United States., Ansstas G; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 May 08; Vol. 14, pp. 1385094. Date of Electronic Publication: 2024 May 08 (Print Publication: 2024).

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation.

Autor: Khaddour K; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Dowling J; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Huang J; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Council M; Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri, USA., Chen D; Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri, USA., Cornelius L; Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri, USA., Johanns T; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Dahiya S; Division of Neuropathology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA., Ansstas G; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.

Publikováno v: Oncotarget [Oncotarget] 2023 Feb 11; Vol. 14, pp. 126. Date of Electronic Publication: 2023 Feb 11.

Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers.

Autor: Varachev, Viacheslav¹ (AUTHOR) varachevviacheslav95@mail.ru, Susova, Olga² (AUTHOR) susovaolga@gmail.com, Mitrofanov, Alexei² (AUTHOR) mitrofanov-aa@list.ru, Naskhletashvili, David² (AUTHOR) nas-david@yandex.ru, Krasnov, George¹ (AUTHOR) gskrasnov@mail.ru, Ikonnikova, Anna¹ (AUTHOR) anyuik@gmail.com, Bezhanova, Svetlana² (AUTHOR) dmitrownaja@gmail.com, Semenova, Vera¹ (AUTHOR) sulpiridum@yandex.ru, Sevyan, Nadezhda² (AUTHOR) hope.sev@ya.ru, Prozorenko, Evgenii² (AUTHOR) prozorenko1984@mail.ru, Ammour, Yulia³ (AUTHOR) yulia.ammour@yahoo.fr, Bekyashev, Ali² (AUTHOR) abekyashev@gmail.com, Nasedkina, Tatiana¹ (AUTHOR) tanased06@rambler.ru

Publikováno v: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13004. 26p.

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma.

Autor: Ma S; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Rudra S; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Campian JL; Department of Medicine, Oncology Division, Washington University School of Medicine, St. Louis, Missouri, USA., Dahiya S; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA., Dunn GP; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Johanns T; Department of Medicine, Oncology Division, Washington University School of Medicine, St. Louis, Missouri, USA., Goldstein M; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Kim AH; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Huang J; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2020 Sep 18; Vol. 2 (1), pp. vdaa126. Date of Electronic Publication: 2020 Sep 18 (Print Publication: 2020).

Research progress on pathogenicity and immune response mechanism of Salmonella infected poultry.

Autor: SHENG Ying-xia, JIANG Hai-yang, GU Hua-bing

Publikováno v: Feed Research. 2024, Vol. 47 Issue 20, p165-171. 7p.